跳至主要内容
临床试验/NL-OMON41748
NL-OMON41748已完成不适用

Immunoadsorption in anti-glomerular basement membrane glomerulonephritis, a pilot study. - Immunoadsorption in anti-GBM glomerulonephritis.

niversitair Medisch Centrum Groningen0 个研究点目标入组 8 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
8

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • Acute renal failure due to anti-GBM glomerulonephritis with or without accompanying pulmonary involvement. Eligible patients must have a clinical picture met rapidly progressive glomerulonephritis in combination with one of the following: 1. serological evidence of circulating anti-GMB antibodies (Dotblot, Phadia, ELISA); 2. Renal biopsy with necrotising glomerulonephritis with linear fluorescence for IgG along the GBM. Notably, in case of serological evidence of circulating anti-GBM antibodies, a renal biopsy is not mandatory for inclusion in this study.

排除标准

  • There are no exclusion criteria. Because of the severity of the disease also patients with a short life expectancy will be included.

研究者

相似试验